[The level of serum thymic activity in patients with rheumatoid arthritis and systemic lupus erythematosus]. 1993

K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova

Thymic serum activity (TSA) has been studied in 52 healthy subjects, 48 rheumatoid arthritis patients and 17 sufferers with systemic lupus erythematosus aged from 18 to 70. TSA was compared in patients under and over 40 years. In those under 40 TSA appeared significantly inhibited, while in older subjects it did not differ from age-matched control. No correlations were reported between TSA levels and clinical characteristics. Changes in TSA levels may be related both to low content of thymic hormones and formation of inactive complexes from thymic mediators with inhibitors.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013935 Thymic Factor, Circulating A thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation. Facteur Thymique Serique,Serum Thymic Factor,Circulating Factor, Thymic,Factor, Thymic Circulating,Nonathymulin,Thymic Serum Factor,Thymulin,Thymuline,Circulating Thymic Factor,Factor, Circulating Thymic,Factor, Serum Thymic,Factor, Thymic Serum,Serique, Facteur Thymique,Serum Factor, Thymic,Thymic Circulating Factor,Thymic Factor, Serum,Thymique Serique, Facteur

Related Publications

K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
January 1981, Clinical immunology and immunopathology,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
January 2023, Current rheumatology reviews,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
November 2017, Clinical and experimental medicine,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
August 1978, Clinica chimica acta; international journal of clinical chemistry,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
February 1985, Clinica chimica acta; international journal of clinical chemistry,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
December 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
January 1993, Terapevticheskii arkhiv,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
July 1988, Annals of the rheumatic diseases,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
January 1970, Naika. Internal medicine,
K S Ternovoĭ, and T N Selezneva, and I M Gandzha, and L Ia Babynina, and A Iu Skorik, and V M Ermekova
March 1958, Annals of the rheumatic diseases,
Copied contents to your clipboard!